Event Overview
What to know about federal court ruling blocking mailing of widely used abortion pill
A pharmaceutical company, Danco Laboratories, filed an emergency motion with the Supreme Court seeking an immediate halt to a federal appeals court ruling that restricts telehealth prescriptions and mail-dispensing of mifepristone. The Fifth Circuit’s decision reinstating in-person visits for mifepristone has been reported, with subsequent court actions affecting access. The New York Times notes that a ruling temporarily halted an FDA regulation expanding access to mifepristone, while another NYT piece states the Fifth Circuit ruling upended access by mandating in-person visits, a ruling that is being appealed. The Hill reports the emergency request to block the appeals-court limits, emphasizing the telehealth and mail-dispensing dimensions.
Concrete downstream impact not stated in the supplied coverage.
Left / left-center
5
Center
1
Right / right-center
0
PBS NewsHour
9/10Factual: very-high · Credibility: high
The Hill
8/10Factual: high · Credibility: high
The New York Times
8/10Factual: high · Credibility: high
CNN
7/10Factual: mostly-factual · Credibility: medium
ABC News
8/10Factual: high · Credibility: high
NBC News
7/10Factual: mostly-factual · Credibility: high
What to know about federal court ruling blocking mailing of widely used abortion pill
Hannah Schoenbaum, Associated Press Hannah Schoenbaum, Associated Press Geoff Mulvihill, Associated Press Geoff Mulvihill, Associated Press In the biggest jolt to abortion policy in the U.S. since the overturning of Roe v. Wade, a federal appeals court has restricted access to one of the most common ways to end early.
Democrats erupt over abortion pill block: ‘We won’t stop fighting’
Democrats are pushing back on a recent court ruling that blocked doctors’ ability to prescribe the abortion pill mifepristone through telehealth and dispense the drug through the mail, arguing it will significantly restrict reproductive care nationwide. “A court packed with Trump-appointed extremists decided to make.
Supreme Court asked to halt limits on mail-order abortion pill Mifepristone
A pharmaceutical company that manufactures and distributes the abortion pill Mifepristone asked the Supreme Court on Saturday to block a federal appeals court ruling prohibiting doctors from prescribing the medication through telehealth services or dispensing it through the mail. New York-based Danco Laboratories.
Supreme Court Asked to Restore Access to Abortion Pill by Mail
A federal appeals court temporarily halted a Food and Drug Administration regulation that has greatly expanded access to the abortion pill mifepristone.
Abortion Providers Forced to Adapt After Court Ruling Blocks Pill Access by Mail
The Fifth Circuit Court’s ruling, which is being appealed, reinstates a requirement that patients visit a health care provider in person to obtain mifepristone, upending abortion access in the United States.
Fight over online access to abortion pill reaches Supreme Court in emergency appeal
The makers of the abortion pill mifepristone filed an emergency appeal at the Supreme Court on Saturday urging the justices to pause a lower-court ruling that temporarily blocked Americans from accessing the drug through the mail. The fast-track case, filed with conservative Justice Samuel Alito, puts the drug and the.
Supreme Court asked to restore access to mail-order abortion pill
An appeals court on Friday barred the telehealth distribution of the pill. A pharmaceutical company that produces mifepristone asked the Supreme Court on Saturday to lift a lower court's ruling prohibiting health providers from dispensing the abortion pill by mail. In an emergency application filed Saturday, Danco.
Supreme Court asked to pause ruling blocking telehealth and mail access to abortion pills
Danco Laboratories, one of the makers of the abortion pill mifepristone, asked the Supreme Court on Saturday to block a lower court ruling that imposed a nationwide requirement for the medication to be dispensed in person. In its filing, the drugmaker also asked the high court to grant an immediate pause of the lower.